Parallax Volatility Advisers’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-50,000
Closed -$233K 1763
2024
Q4
$233K Hold
50,000
﹤0.01% 1638
2024
Q3
$347K Hold
50,000
﹤0.01% 1590
2024
Q2
$390K Buy
+50,000
New +$370K ﹤0.01% 1483
2022
Q1
Sell
-300
Closed -$10K 2865
2021
Q4
$10K Sell
300
-115,700
-100% -$4.65M ﹤0.01% 1929
2021
Q3
$4.76M Buy
+116,000
New +$4.21M ﹤0.01% 848
2021
Q1
Sell
-153,200
Closed -$6.18M 1393
2020
Q4
$6.18M Buy
+153,200
New +$7.04M 0.01% 870

Other funds holding GDRX

Parallax Volatility Advisers's GDRX Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of GoodRx Holdings (GDRX) in Q1 2025, closing a stake of 43,877 shares — an estimated $204K sold.

Parallax Volatility Advisers first reported a position in GDRX in Q4 2020 and held it in 5 quarters. The position peaked at $1.51M in Q4 2020. 170 funds tracked by Wall St. Rank hold GDRX as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining GoodRx Holdings position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 43,877 GoodRx Holdings shares in Q1 2025, an estimated $204K.
  • Parallax Volatility Advisers first reported a position in GoodRx Holdings in Q4 2020 and held it in 5 quarters.
  • Parallax Volatility Advisers's GoodRx Holdings position peaked at $1.51M in Q4 2020.
  • 170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.